Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
ACS Infectious Diseases
|
January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis
William G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry
|
June 19, 2015
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery
William Devine, Jennifer L Woodring, Uma Swaminathan, et al.
Plos One
|
February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production
Margaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
ACS Infectious Diseases
|
March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?
Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>
Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
ACS Medicinal Chemistry Letters
|
October 23, 2018
Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation
Jennifer L Woodring, Ranjan Behera, Amrita Sharma, et al.
Journal of Medicinal Chemistry
|
January 25, 2023
Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery
Baljinder Singh, Amrita Sharma, Naresh Gunaganti, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development
Kelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Molecular Pharmacology
|
August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo
Ashley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Journal of Medicinal Chemistry
|
November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics
Dana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
ACS Infectious Diseases
|
January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis
William G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry
|
June 19, 2015
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery
William Devine, Jennifer L Woodring, Uma Swaminathan, et al.
Plos One
|
February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production
Margaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
ACS Infectious Diseases
|
March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?
Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>
Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
ACS Medicinal Chemistry Letters
|
October 23, 2018
Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation
Jennifer L Woodring, Ranjan Behera, Amrita Sharma, et al.
Journal of Medicinal Chemistry
|
January 25, 2023
Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery
Baljinder Singh, Amrita Sharma, Naresh Gunaganti, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development
Kelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Molecular Pharmacology
|
August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo
Ashley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Journal of Medicinal Chemistry
|
November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics
Dana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Page
of 8